- Status:
- Topic selection
- Technology type:
- Medicine
- Decision:
- Not selected
- Reason for decision:
- Not eligible for Health Technology Evaluation guidance
- Further information:
- Decision makers have concluded that the clear rationale to not evaluate this product is due to a clinical guideline (CG61) being available that already which includes a recommendation for the use of Linaclotide acetate for treating Chronic idiopathic constipation. Therefore, a TA would not add any further value.
- ID number:
- 12005
Project Team
- Project lead
- Danielle Lees
Email enquiries
If you have any queries please email [email protected]
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 10 September 2024 | Topic selection |
For further information on how we select topics for development, please see our page about prioritising our guidance topics